← All companiesEEyePoint Pharmaceuticals, Inc.
EYPT - CIK 0001314102
EyePoint Pharmaceuticals, Inc. net income by year
EyePoint Pharmaceuticals, Inc. (EYPT) reported net income of -$231.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
EYPT annual net income
EYPT net income 2011-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$231.96M | -77.2% |
| FY 2024 | -$130.87M | -84.9% |
| FY 2023 | -$70.80M | +30.8% |
| FY 2022 | -$102.25M | -75.0% |
| FY 2021 | -$58.42M | -28.7% |
| FY 2020 | -$45.39M | +20.1% |
| FY 2019 | -$56.79M | +34.1% |
| FY 2018 | -$86.13M | -365.9% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does EyePoint Pharmaceuticals, Inc. make?
EyePoint Pharmaceuticals, Inc. (EYPT) reported net income of -$231.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has EyePoint Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, EyePoint Pharmaceuticals, Inc.'s net income declined from -$8.63M to -$231.96M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.